DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Domchek SM, Aghajanian C, Shapira-Frommer R. et al.
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy.
Gynecol Oncol 2016;
140: 199-203
DOI: 10.1016/j.ygyno.2015.12.020.
We do not assume any responsibility for the contents of the web pages of other providers.